DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Wassef MAE, Tork OM, Rashed LA. et al.
Mitochondrial dysfunction in diabetic cardiomyopathy: Effect of mesenchymal stem cell with ppar-γ agonist or exendin-4.
Exp Clin Endocrinol Diabetes. 2017;
DOI: 10.1055/s-0043-106859.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.